Bank of Montreal’s Ascendis Pharma A/S ASND Stock Holding History

Bank of Montreal’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,190	Closed	-$1.23K	–	4067
2022 Q2	$1.23K	Buy	+13,190	New	+$1.24M	﹤0.01%	2183
2021 Q2	–	Sell	-590	Closed	-$76K	–	3720
2021 Q1	$76K	Hold	590	–	–	﹤0.01%	3521
2020 Q4	$102K	Hold	590	–	–	﹤0.01%	3567
2020 Q3	$96K	Hold	590	–	–	﹤0.01%	3095
2020 Q2	$83K	Hold	590	–	–	﹤0.01%	3179
2020 Q1	$65K	Sell	590 -1,434	-71%	-$186K	﹤0.01%	2788
2019 Q4	$282K	Sell	2,024 -43	-2%	-$4.78K	﹤0.01%	2974
2019 Q3	$199K	Buy	2,067 +43	+2%	+$4.8K	﹤0.01%	2914
2019 Q2	$233K	Sell	2,024 -1,372	-40%	-$164K	﹤0.01%	2840
2019 Q1	$400K	Buy	3,396 +88	+3%	+$7.71K	﹤0.01%	2397
2018 Q4	$207K	Hold	3,308	–	–	﹤0.01%	2555
2018 Q3	$234K	Hold	3,308	–	–	﹤0.01%	2660
2018 Q2	$220K	Hold	3,308	–	–	﹤0.01%	2717
2018 Q1	$216K	Sell	3,308 -790	-19%	-$44.4K	﹤0.01%	2595
2017 Q4	$164K	Hold	4,098	–	–	﹤0.01%	2767
2017 Q3	$149K	Sell	4,098 -437	-10%	-$12.5K	﹤0.01%	2790
2017 Q2	$126K	Buy	4,535 +2,541	+127%	+$67.1K	﹤0.01%	2881
2017 Q1	$56K	Buy	+1,994	New	+$50.4K	﹤0.01%	3041

Other funds holding ASND

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bank of Montreal's ASND Position: Q3 2022 in Review

Bank of Montreal sold out of Ascendis Pharma A/S (ASND) in Q3 2022, closing a stake of 13,190 shares — an estimated $1.23K sold.

Bank of Montreal first reported a position in ASND in Q1 2017 and held it in 18 quarters. The position peaked at $400K in Q1 2019. 183 funds tracked by Wall St. Rank hold ASND as of Q3 2022.

Bank of Montreal reported no remaining Ascendis Pharma A/S position as of Q3 2022 after selling out during the quarter.
Bank of Montreal sold 13,190 Ascendis Pharma A/S shares in Q3 2022, an estimated $1.23K.
Bank of Montreal first reported a position in Ascendis Pharma A/S in Q1 2017 and held it in 18 quarters.
Bank of Montreal's Ascendis Pharma A/S position peaked at $400K in Q1 2019.
183 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.